Curative Labs Inc

3330 New York Ave NE

Washington, DC 20002
support@curative.com
Final Results
Report

Patient Name: Pitetta, Facundo Facility: Camillus House - FL

Patient MRN: CUR167052664 Requisition: 54803424

Date of Birth: 1995-10-06 (26 years old) Kit ID: A311185391364

Sex: male Collected: 01/21/22 11:42:07 AM EST

Address: 7330 Northwest 36th Street Miami, FL 33166 Received: 01/22/22 12:03:31 PM EST

Phone Number: (954) 469-6111 Released: 01/23/22 12:53:01 AM EST

Email: facundopitetta@icloud.com Specimen Type: Alinity shallow nasal swab

Physician: Zalzala, Sajad

(1639311509)

Test Result

SARS-CoV-2 Assay (RNA Detection Test by RT-qPCR) Positive

Interpretation:

Positive: SARS-CoV-2 RNA detected by RT-qPCR

Negative: SARS-CoV-2 RNA not detected by RT-qPCR
Indeterminate: Indeterminate for SARS-CoV-2 RNA by RT-qPCR.

Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical

correlation with patient history and other diagnostic information is
necessary
to determine patient infection status. Positive results do not
rule out bacterial infection or co-infection with other viruses. The agent
detected may not be
the definite cause of disease. Laboratories within the
United States and its territories are required to report all positive
results to the appropriate public
health authorities.

Negative results do not preclude SARS-CoV-2 infection and should not be used
as the sole basis for patient management decisions. Inadequate sample
collection or exposure to extreme heat during transport may decrease the
ability to detect SARS-CoV-2 RNA in a sample. Negative results must be
combined with clinical observations, patient history, and epidemiological
information.

Indeterminate results means that the test was not able to clearly determine
whether SARS-CoV-2 was or was not present and may occur in the case of an
inadequate specimen. Specimen must be recollected if test is still required.

Method: Real-Time Reverse-Transcription PCR

This test is based on the CDC SARS-CoV-2 assay, a real-time

reverse-transcription polymerase chain reaction (RT-PCR) test that detects
RNA from
SARS-CoV-2 in upper or lower respiratory specimens. The test has
been optimized to be performed on the BioRad CFX Real-Time PCR detection
system
and uses high throughput technologies.

Disclaimer:

This SARS-CoV-2 PCR test was developed and its performance characteristics
were determined by Curative Labs. This test has not been cleared,
approved
or authorized by the U.S. Food and Drug Administration (FDA). This test may
be used for clinical purposes and should not be regarded as
investigational
or for research only. Curative Laboratory is certified under the Clinical
Laboratory Improvement Amendments of 1988 (CLIA) as qualified to
perform
high complexity clinical laboratory testing. The results are not intended to
be used as the sole means for clinical diagnosis or patient management
decisions.

Lab director: Arthur Baca MD, PhD; CLIA # 09D2180856; Sample

reviewed at: 01/23/22 12:23:01 AM EST; Report generated at:
01/23/22 07:55:50 AM
EST